BRCA1, BRCA2 and breast cancer: a concise clinical review

Carter, Ronald F.
June 2001
Clinical & Investigative Medicine;Jun2001, Vol. 24 Issue 3, p147
Academic Journal
Focuses on the clinical indications of hereditary breast cancer. Clinical indications of BRCA1- and BRCA2-associated breast cancer; Pathogenic mechanisms of BRCA1 and BRCA2; Laboratory tests for mutations of BRCA1 and BRCA2.


Related Articles

  • Poster presentations: 1. Clinical Genetics/Counselling.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS41 

    Discusses the abstract of the research paper entitled 'Breast cancer: South Asian patients' experience, attitude, beliefs and perception of genetic risk,' by Gulshan Karbani, K.M. Atkin et al and presented during the British Human Genetics Conference at the University of York in England in...

  • Popularity of breast cancer program leads to referral protocols in BC. Kent, Heather // CMAJ: Canadian Medical Association Journal;10/06/98, Vol. 159 Issue 7, p832 

    Discusses a British Columbia program which tests patients for susceptibility to hereditary breast cancer. Popularity of the Hereditary Cancer Program; Detailed protocol for referral which has been sent to physicians in an attempt to curb the surging number of patients; Screening questionnaire;...

  • Large Genomic Rearrangements of BRCA1 and BRCA2 among Patients Referred for Genetic Analysis in Galicia (NW Spain): Delimitation and Mechanism of Three Novel BRCA1 Rearrangements. Fachal, Laura; Blanco, Ana; Santamariña, Marta; Carracedo, Angel; Vega, Ana // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    In the Iberian Peninsula, which includes mainly Spain and Portugal, large genomic rearrangements (LGRs) of BRCA1 and BRCA2 have respectively been found in up to 2.33% and 8.4% of families with hereditary breast and/or ovarian cancer (HBOC) that lack point mutations and small indels. In Galicia...

  • Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications. Scumaci, Domenica; Tammè, Laura; Fiumara, Claudia Vincenza; Pappaianni, Giusi; Concolino, Antonio; Leone, Emanuela; Faniello, Maria Concetta; Quaresima, Barbara; Ricevuto, Enrico; Costanzo, Francesco Saverio; Cuda, Giovanni // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background: Breast cancer (BC) is a leading cause of death among women. Among the major risk factors, an important role is played by familial history of BC. Germ-line mutations in BRCA1/2 genes account for most of the hereditary breast and/or ovarian cancers. Gene expression profiling studies...

  • Role of genetic factors in breast cancer. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;04/25/97, Vol. 10 Issue 4, p25 

    Focuses on the role of genetics in breast cancer. High level of risk in women with mutated BRCA1 and BRCA2 genes; Development of multiple cancers by individuals with the Li-Fraumeni syndrome.

  • Genetic mutations and risk of breast cancer.  // CMAJ: Canadian Medical Association Journal;07/15/97, Vol. 157 Issue 2, p130 

    Reports on the role of genetic mutation in developing breast cancer. How some families and ethnic groups have a higher risk with mutations in the BRCA1 and BRCA2 genes; How the research was focused on subjects of Ashkenazi Jewish ancestry.

  • The genetic moral code. Gore, Al // Advocate;03/31/98, Issue 756, p9 

    Encourages the use of advances in genetic research for positive rather than destructive outcomes. Impetus to ensure that advances in genetics are used properly; Reason women do not get genetic testing for susceptibility to breast cancer; Information about the proposed legislation for the...

  • 694. Breast Cancer Specificity, Anti-Tumor Activity, and Reduced Toxicity of an Adenoviral Vector Encoding Interleukin-2 under Control of the Human Mammaglobin Promoter Hew, Paggy; Shi, Changxin; Paiva, Melissa; Robertson, Jen; Ying, Chuyan; Graham, Frank L.; Addison, Christina; Gauldie, Jack; Hitt, Mary M. // Molecular Therapy;Jun2005, Vol. 11, p269 

    An abstract of the article "Breast Cancer Specificity, Anti-Tumor Activity, and Reduced Toxicity of an Adenoviral Vector Encoding Interleukin-2 under Control of the Human Mammaglobin Promoter," by Paggy Hew, Changxin Shi, Melissa Paiva, Frank L. Graham, Christina Addison, Jack Gauldie is presented.

  • Nature: Understanding breast cancer.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that the researchers have identified several mutated genes which are responsible for causing breast cancer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics